Late Recurrence of Hepatocellular Carcinoma in a Patient 10 Years after Liver Transplantation Unrelated to Transplanted Organ

Liver transplantation (LTx) is an accepted method of hepatocellular carcinoma (HCC) treatment in cirrhotic patients; however, it has many limitations, and there is a substantial risk of recurrence. Most relapses occur within the first 2 posttransplant years. We aimed to present a late extrahepatic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Morisson-Sarapak, Kornelia, Wrzesiński, Maciej, Zeair, Samir, Wawrzynowicz-Syczewska, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739982/
https://www.ncbi.nlm.nih.gov/pubmed/35082636
http://dx.doi.org/10.1159/000520535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739982/
https://www.ncbi.nlm.nih.gov/pubmed/35082636
http://dx.doi.org/10.1159/000520535

Ejemplares similares